Bayer Cropscience Latest Share Price (BAYERCROP)
TODAY IN ONE LINE
BAYERCROP is little changed at ₹4089.30 on light volume — a quiet consolidation day, hovering dangerously near its 52-week low.
With a market cap of ₹18,378.17 Cr., it trades at a P/E of 25.07. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Bayer Cropscience flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 13.1% YoY
- ●High Capital EfficiencyROCE of 20.1% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 15.8%
- ●High Promoter HoldingPromoters hold 71.4% skin-in-the-game
- ●Steady Dividend YieldReliable 3.67% dividend yield
- ●Positive Free Cash FlowFCF has been positive for 3 consecutive years
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest Bayer Cropscience News
What changed recently?
Recent events, corporate actions, and announcements.
Bayer Cropscience Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Bayer Cropscience Limited, framed against the sector median so the premium or discount is obvious at a glance.
Bayer Cropscience Limited trades at a P/E of 25.07× and P/B of 6.19×, against the Chemicals sector median P/E of 44.73×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Bayer Cropscience Limited technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for Bayer Cropscience Limited — derived from the latest tape, not yesterday's close.
Bayer Cropscience Limited last traded at ₹4,089.3 with an intraday range of ₹4,074–₹4,105 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹4089.30| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 4166.87 | +77.57 | +1.90% |
| R3 | 4135.87 | +46.57 | +1.14% |
| R2 | 4120.43 | +31.13 | +0.76% |
| R1 | 4104.87 | +15.57 | +0.38% |
| PIVOT | 4089.43 | 0.13 | 0.00% |
| CURRENT | 4089.30 | — | — |
| S1 | 4073.87 | -15.43 | -0.38% |
| S2 | 4058.43 | -30.87 | -0.75% |
| S3 | 4042.87 | -46.43 | -1.14% |
| S4 | 4011.87 | -77.43 | -1.89% |
BAYERCROP is trading Below CPR, indicating Bearishness
CPR is Narrower, suggesting likely for trending moves
Day's range: ₹4074–₹4095
Trading Inside opening range
Bayer Cropscience Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Bayer Cropscience Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Bayer Cropscience Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹18,378.17 Cr. and reported EPS of ₹162.76.
Bayer Cropscience segment analysis : revenue and profit mix.
Disclosed business segments at Bayer Cropscience with their share of revenue and profit, switchable between consolidated and standalone reporting.
Bayer Cropscience discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Bayer Cropscience Limited.
Our AI distills the core fundamental drivers supporting Bayer Cropscience Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Bayer Cropscience Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
ROE 23.70% and ROCE 20.10% substantially exceed sector peer averages significantly.
Operating margin 13.74% demonstrates strong pricing power and operational efficiency.
Promoter holding 71.44% ensures stable long-term management alignment and commitment.
Debt-to-equity 0.0034x with minimal ₹112 Cr debt signals fortress balance sheet.
Dividend yield 3.03% supported by ₹239.98 cash per share provides income stability.
Key Risks.
Latest quarterly EPS grew 13.1% YoY yet TTM revenue growth modest at 5.1%.
Stock trades 29% below 52-week high ₹5,525, indicating recent valuation correction.
P/E 27.25x elevated relative to peer median, limiting margin of safety.
Payout ratio 81.58% constrains reinvestment capacity for future growth initiatives.
Beta 0.5338 suggests low market correlation, potentially limiting upside participation.
Flip Conditions.
Valuation risk. a P/E above 33 (~0.7× the sector multiple of 44.7) would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 11% would indicate weaker capital compounding.
Bayer Cropscience Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Bayer Cropscience Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Bayer Cropscience Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Bayer Cropscience Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
Bayer Cropscience Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Bayer Cropscience Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Bayer Cropscience Limited stood at 57.5% of traded volume, against a 20-day average of 58.9%.
Bayer Cropscience announcements: results, concalls, ratings, M&A.
Filings Bayer Cropscience sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Bayer Cropscience files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 69 documents below.
AGM/EGM
Disclosure of the voting results of the 68th AGM of the Company along with scrutinizer''s report.
AGM/EGM
Pursuant to Regulation 30 of SEBI Listing Regulations, 2015, please find attached summary of proceedings/outcome of 68th AGM of the Company held on…
Company Update
Attached the Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2026.
Company Update
Newspaper Publication in Financial Express and Loksatta for information regarding 68th Annual General Meeting of the Company to be held via VC/OAVM,…
Company Update
Please find attached herewith a communication sent to the Shareholders of the Company in relation to Tax Deducted at Source on Dividend.
Investor decks & rating reports.
Bayer Cropscience dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Bayer Cropscience has declared, sequenced by announce and record date.
Bayer Cropscience corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Bayer Cropscience Limited: business, sector, key facts.
What Bayer Cropscience Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Bayer Cropscience Limited operates in the Pesticides & Agrochemicals industry under the Chemicals sector, listed as NSE: BAYERCROP, BSE: 506285.
Bayer CropScience Limited is a multinational corporation primarily focused on the agricultural sector, with significant operations in India, Germany, Bangladesh, and other international markets. Its core business revolves around the research, development, manufacturing, sale, and distribution of a wide range of agrochemical products. This includes insecticides, fungicides, and herbicides designed to protect crops from pests and diseases, contributing significantly to global food security. The company also plays a key role in the seed industry, offering high-yielding hybrid seeds, notably corn and paddy, to farmers worldwide.
Beyond its agrochemical and seed offerings, Bayer CropScience is deeply involved in providing advanced digital farming solutions. These solutions leverage modern technologies like remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to optimize crop management. Specific examples include the FarmRise platform and drone services for efficient crop spraying. This commitment to technological innovation reflects a strategic aim to enhance agricultural productivity and sustainability through precise data-driven farming practices. The integration of digital technologies strengthens Bayer CropScience's position as a comprehensive agricultural solutions provider.
While the company's primary focus is agriculture, Bayer CropScience also has a presence in other healthcare-related sectors. This includes the production and distribution of pharmaceuticals across various therapeutic areas such as cardiology, gynecology, diabetes, oncology, and ophthalmology. Furthermore, it offers medical imaging equipment like computed tomography, X-ray, and magnetic resonance imaging devices. In addition to these therapeutic and diagnostic offerings, Bayer CropScience also manufactures and sells consumer health products targeted at managing minor ailments. This diversified portfolio contributes to a more resilient business model, spreading risk and providing diverse revenue streams.
The company's long history, tracing back to its founding in 1863, underscores its experience and established presence in global markets. It maintains a significant export business, further solidifying its international reach and influence. Headquartered in Thane, India, Bayer CropScience's operations are strategically positioned to address the needs of a rapidly growing global population and the ever-evolving demands of modern agriculture. The company continuously strives to improve farming efficiency and sustainability, leading to enhanced food production and a positive impact on the agricultural landscape.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Advance Agrolife (ADVANCE) Share PricePeer
- Agro Phos India (AGROPHOS) Share PricePeer
- Arvee Laboratories (India) (ARVEE) Share PricePeer
- Best Agrolife (BESTAGRO) Share PricePeer
- Black Rose Industries (BLACKROSE) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Top quality scorecard stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Bayer Cropscience Limited (BAYERCROP).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Bayer Cropscience Limited (BAYERCROP)?
The current share price of Bayer Cropscience Limited (BAYERCROP) is ₹4,089.30. Today, the stock has declined by ₹0.20 (0%), trading in a range of ₹4,074.00 to ₹4,105.00. The stock opened at ₹4,077.00 with a trading volume of 11,131 shares.
02Is Bayer Cropscience Limited stock a good investment for long-term?
Bayer Cropscience Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹18,378.17 Cr., P/E ratio of 25.07, ROE of 15.8%, and ROCE of 20.1%. The dividend yield stands at 3.67%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Bayer Cropscience Limited stock?
The 52-week high price of Bayer Cropscience Limited (BAYERCROP) is ₹5,525.00, while the 52-week low is ₹4,030.00. Currently trading at ₹4,089.30, the stock is 1.47% above its 52-week low and 25.99% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Bayer Cropscience Limited stock at the current price?
Whether to buy Bayer Cropscience Limited stock at ₹4,089.30 depends on multiple factors. The stock is currently trading with a P/E ratio of 25.07 and P/B ratio of 6.19. Today's performance shows a loss of 0%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Bayer Cropscience Limited and when is the next dividend?
Bayer Cropscience Limited offers a dividend yield of 3.67%, which means for every ₹100 invested at the current price of ₹4,089.30, you can expect to receive approximately ₹3.67 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Bayer Cropscience Limited?
Bayer Cropscience Limited's key financial metrics include: P/E Ratio: 25.07, P/B Ratio: 6.19, ROE: 15.8%, ROCE: 20.1%, Dividend Yield: 3.67%, EPS: ₹162.76, Book Value: ₹659.89, and Debt-to-Equity: 0.34. The company's market cap stands at ₹18,378.17 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Bayer Cropscience Limited stock performing today in the market?
Bayer Cropscience Limited stock opened at ₹4,077.00 and is currently trading at ₹4,089.30, showing a decline of ₹0.20 (0%). The intraday high is ₹4,105.00 and low is ₹4,074.00. The trading volume stands at 11,131 shares, indicating moderate market participation today.
08What is the P/E ratio of Bayer Cropscience Limited and what does it indicate?
Bayer Cropscience Limited has a Price-to-Earnings (P/E) ratio of 25.07, which means investors are willing to pay 25.07 for every ₹1 of earnings. With an EPS of ₹162.76, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Bayer Cropscience Limited (BAYERCROP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.